The Enterprise Value as of December 2025 (TTM) for Genor Biopharma Holdings Limited (6998.HK) is 784.14M

According to Genor Biopharma Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 784.14M. This represents a change of -364.19% compared to the average of -296810102.84 of the last 4 quarters.

Genor Biopharma Holdings Limited (6998.HK) Historical Enterprise Value (quarterly & annually)

How has 6998.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Genor Biopharma Holdings Limited over the last ten years is 4.05B. The current 784.14M Enterprise Value has changed 1.84% with respect to the historical average. Over the past ten years (40 quarters), 6998.HK's Enterprise Value was at its highest in in the June 2020 quarter at 12.45B. The Enterprise Value was at its lowest in in the December 2023 quarter at -621114567.23.

Genor Biopharma Holdings Limited (6998.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genor Biopharma Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genor Biopharma Holdings Limited (6998.HK) Average Enterprise Value

How has 6998.HK Enterprise Value performed in the past?

The current Enterprise Value of Genor Biopharma Holdings Limited (6998.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genor Biopharma Holdings Limited (6998.HK) Enterprise Value vs. Peers

How is 6998.HK’s Enterprise Value compared to its peers?

Genor Biopharma Holdings Limited’s Enterprise Value is less than Immunotech Biopharm Ltd (1.47B), less than JW (Cayman) Therapeutics Co. Ltd (932.28M), less than 3D Medicines Inc. (1.25B), greater than Zhaoke Ophthalmology Limited (772.54M), less than BioDlink International Company Limited (1.22B), less than Transcenta Holding Limited (1.19B), greater than Brii Biosciences Limited (-446421180.26), less than Wuhan YZY Biopharma Co Ltd (1.24B), less than Rici Healthcare Holdings Limited (2.60B), less than Sunho Biologics, Inc. (878.63M),

Build a custom stock screener for Genor Biopharma Holdings Limited (6998.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genor Biopharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genor Biopharma Holdings Limited (6998.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genor Biopharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.